Exorbitant costs to see specialist doctors risk leaving Aussies sicker and hospitals under more pressure, as a new report urges a boost in government fundi ...

In a multicenter Phase III trial spanning eight leading clinical hospitals in China, Azstarys demonstrated statistically significant improvements over placebo in primary and secondary efficacy ...